Engaged Capital’s Medifast MED Stock Holding History

Engaged Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-267,543	Closed	-$44M	–	11
2020 Q3	$44M	Sell	267,543 -892,833	-77%	-$147M	4.55%	6
2020 Q2	$161M	Hold	1,160,376	–	–	17.35%	2
2020 Q1	$72.5M	Hold	1,160,376	–	–	9.51%	3
2019 Q4	$127M	Buy	1,160,376 +647,853	+126%	+$62.7M	13.21%	3
2019 Q3	$53.1M	Buy	+512,523	New	+$55.1M	6.73%	4
2019 Q2	–	Sell	-11,242	Closed	-$1.43M	–	11
2019 Q1	$1.43M	Buy	+11,242	New	+$1.43M	0.2%	12
2018 Q1	–	Sell	-264,549	Closed	-$18.5M	–	17
2017 Q4	$18.5M	Sell	264,549 -525,000	-66%	-$34.8M	2.34%	8
2017 Q3	$46.9M	Hold	789,549	–	–	5.76%	5
2017 Q2	$32.7M	Hold	789,549	–	–	4.86%	5
2017 Q1	$35M	Buy	789,549 +17,084	+2%	+$735K	8.89%	5
2016 Q4	$32.2M	Buy	772,465 +35,000	+5%	+$1.41M	10.48%	4
2016 Q3	$27.9M	Hold	737,465	–	–	10.15%	5
2016 Q2	$24.5M	Hold	737,465	–	–	8.63%	4
2016 Q1	$22.3M	Hold	737,465	–	–	7.51%	5
2015 Q4	$22.4M	Hold	737,465	–	–	13.91%	3
2015 Q3	$19.8M	Buy	737,465 +1,199	+0.2%	+$34.9K	11.36%	3
2015 Q2	$23.8M	Buy	736,266 +117,596	+19%	+$3.73M	13.69%	3
2015 Q1	$18.5M	Buy	618,670 +7,061	+1%	+$224K	13.84%	3
2014 Q4	$20.5M	Buy	611,609 +23,609	+4%	+$735K	16.75%	3
2014 Q3	$19.3M	Buy	588,000 +30,000	+5%	+$921K	14.27%	2
2014 Q2	$17M	Sell	558,000 -42,000	-7%	-$1.31M	11.77%	3
2014 Q1	$17.5M	Buy	+600,000	New	+$16.1M	11.98%	2

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Engaged Capital's MED Position: Q4 2020 in Review

Engaged Capital sold out of Medifast (MED) in Q4 2020, closing a stake of 267,543 shares — an estimated $44M sold.

Engaged Capital first reported a position in MED in Q1 2014 and held it in 22 quarters. The position peaked at $161M in Q2 2020. 261 funds tracked by Wall St. Rank hold MED as of Q4 2020.

Engaged Capital reported no remaining Medifast position as of Q4 2020 after selling out during the quarter.
Engaged Capital sold 267,543 Medifast shares in Q4 2020, an estimated $44M.
Engaged Capital first reported a position in Medifast in Q1 2014 and held it in 22 quarters.
Engaged Capital's Medifast position peaked at $161M in Q2 2020.
261 funds tracked by Wall St. Rank held Medifast as of Q4 2020.

Based on Engaged Capital's 13F filing for Q4 2020, filed 16 Feb 2021.